SCLX
Scilex Holding Co
Company overview
- Market capitalization
- $38.13M
- Employees
- 34
- Latest publication
- 2026-09-29
About Scilex Holding Co
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA; and Tulex Master, which develops, tests, and manufactures clinical supplies of SP-104. Scilex Holding Company is based in Palo Alto, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,642,000USD | 8,613,000USD | 4,793,000USD | 10,560,000USD | 9,896,000USD | 5,004,000USD | 14,900,000USD | 14,436,000USD |
| Cost Of Revenue | 8,119,000USD | 4,447,000USD | 2,614,000USD | 3,329,000USD | 3,272,000USD | 1,384,000USD | 4,691,000USD | 3,768,000USD |
| Gross Profit | 15,800,000USD | 4,166,000USD | 2,179,000USD | 7,231,000USD | 6,624,000USD | 3,620,000USD | 10,209,000USD | 10,668,000USD |
| Research Development | 3,336,000USD | 3,210,000USD | 8,168,000USD | 3,899,000USD | 6,187,000USD | 2,456,000USD | 2,180,000USD | 2,349,000USD |
| Selling General Administrative | 27,960,000USD | 31,033,000USD | 30,159,000USD | 188,824,000USD | 19,841,000USD | 28,060,000USD | 35,406,000USD | 29,734,000USD |
| Total Operating Expenses | 45,223,000USD | 36,335,000USD | 42,275,000USD | 193,743,000USD | 27,131,000USD | 31,518,000USD | 38,587,000USD | 36,853,000USD |
| Operating Income | -29,423,000USD | -32,169,000USD | -37,482,000USD | -186,512,000USD | -20,507,000USD | -27,898,000USD | -28,378,000USD | -22,417,000USD |
| Total Other Income Expense Net | -85,556,000USD | -13,481,000USD | -5,119,000USD | -71,307,000USD | -23,522,000USD | 1,818,000USD | 21,917,000USD | 18,605,000USD |
| Interest Expense | 6,104,000USD | 3,779,000USD | 3,498,000USD | 2,798,000USD | 2,682,000USD | 2,481,000USD | 285,000USD | 576,000USD |
| Income Before Tax | -114,979,000USD | -45,650,000USD | -46,099,000USD | -257,819,000USD | -44,029,000USD | -26,080,000USD | -6,461,000USD | -4,388,000USD |
| Income Tax Expense | 7,000USD | 5,999USD | — | -1,000USD | 19,000USD | -1,000USD | -1,000USD | — |
| Net Income | -114,986,000USD | -43,270,000USD | -33,112,000USD | -257,234,000USD | -86,061,000USD | -26,080,000USD | -6,460,000USD | -4,388,000USD |
| Minority Interest | -1,486,000USD | 2,380,000USD | 12,993,000USD | 586,000USD | 1,740,000USD | 0USD | — | 0USD |
| Net Income Applicable To Common Shares | -114,729,000USD | — | — | — | — | — | — | — |
| Unclassified Operating Expenses | — | 2,092,000USD | 3,948,000USD | — | 1,103,000USD | 1,002,000USD | 1,001,000USD | 4,770,000USD |
| Net Income From Continuing Ops | — | -45,650,000USD | -46,105,000USD | -257,820,000USD | -44,048,000USD | -26,080,000USD | -6,460,000USD | -4,388,000USD |
| Ebit | — | -32,169,000USD | — | -255,021,000USD | -41,347,000USD | -23,599,000USD | -6,176,000USD | — |
| Ebitda | — | -29,300,000USD | — | -253,998,000USD | -40,337,000USD | -22,596,000USD | -5,172,000USD | — |
| Depreciation And Amortization | — | 2,869,000USD | — | 1,023,000USD | 1,010,000USD | 1,003,000USD | 1,004,000USD | — |
| Reconciled Depreciation | — | 2,869,000USD | 1,587,000USD | 1,023,000USD | 1,010,000USD | 1,003,000USD | 1,004,000USD | 1,005,000USD |
| Net Interest Income | — | — | -3,498,000USD | -2,798,000USD | -2,682,000USD | -2,481,000USD | -285,000USD | -576,000USD |
| Tax Provision | — | — | 6,000USD | 1,000USD | 19,000USD | — | -1,000USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 30,253,000USD | 56,590,000USD | 46,743,000USD | 38,034,000USD | 31,317,000USD | 23,560,000USD | 21,033,000USD |
| Cost Of Revenue | 15,222,000USD | 16,689,000USD | 15,681,000USD | 10,797,000USD | 3,634,000USD | 2,149,000USD | 5,802,000USD |
| Gross Profit | 15,031,000USD | 39,901,000USD | 31,062,000USD | 27,237,000USD | 27,683,000USD | 21,411,000USD | 15,231,000USD |
| Research Development | 20,710,000USD | 9,641,000USD | 12,746,000USD | 9,054,000USD | 9,201,000USD | 9,961,000USD | 85,517,000USD |
| Selling General Administrative | 266,884,000USD | 119,016,000USD | 119,645,000USD | 64,895,000USD | 50,582,000USD | 42,970,000USD | 64,696,000USD |
| Total Operating Expenses | 287,335,000USD | 123,297,000USD | 136,493,000USD | 77,871,000USD | 63,521,000USD | 56,669,000USD | 153,926,000USD |
| Operating Income | -272,304,000USD | -83,396,000USD | -105,431,000USD | -50,634,000USD | -35,838,000USD | -35,258,000USD | -138,695,000USD |
| Interest Expense | 11,459,000USD | 1,963,000USD | 1,068,000USD | 9,604,000USD | 11,764,000USD | 13,116,000USD | 16,889,000USD |
| Net Interest Income | -11,459,000USD | -1,963,000USD | -1,525,000USD | -9,604,000USD | -39,764,000USD | -13,116,000USD | -16,429,000USD |
| Income Before Tax | -374,027,000USD | -72,808,000USD | -114,318,000USD | -23,360,000USD | -88,419,000USD | -47,572,000USD | -178,592,000USD |
| Income Tax Expense | 26,000USD | -1,000USD | 13,000USD | 4,000USD | 5,000USD | -53,000USD | 2,000USD |
| Tax Provision | 26,000USD | -1,000USD | 45,000USD | 4,000USD | 5,000USD | -53,000USD | 2,000USD |
| Net Income | -358,734,000USD | -72,807,000USD | -114,331,000USD | -23,364,000USD | -88,424,000USD | -47,519,000USD | -178,594,000USD |
| Net Income From Continuing Ops | -374,053,000USD | -72,807,000USD | -110,815,000USD | -23,364,000USD | -1,005,498USD | -47,519,000USD | -178,594,000USD |
| Ebit | -272,304,000USD | -70,845,000USD | -113,250,000USD | -13,756,000USD | -76,655,000USD | -35,258,000USD | -161,703,000USD |
| Ebitda | -267,681,000USD | -66,799,000USD | -109,104,000USD | -9,303,000USD | -72,876,000USD | -31,481,000USD | -157,953,000USD |
| Depreciation And Amortization | 4,623,000USD | 4,046,000USD | 4,146,000USD | 4,453,000USD | 3,779,000USD | 3,777,000USD | 3,750,000USD |
| Reconciled Depreciation | 4,623,000USD | 4,046,000USD | 4,147,000USD | 3,961,000USD | 3,779,000USD | 3,777,000USD | 3,750,000USD |
| Total Other Income Expense Net | -101,723,000USD | 10,588,000USD | -8,887,000USD | 27,274,000USD | -52,581,000USD | -12,314,000USD | -39,897,000USD |
| Minority Interest | 15,319,000USD | 0USD | — | — | — | — | — |
| Unclassified Operating Expenses | — | -5,360,000USD | 4,102,000USD | 3,922,000USD | 3,738,000USD | 3,738,000USD | 3,713,000USD |
| Non Operating Income Net Other | — | — | — | 36,878,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | -23,364,000USD | 783,438USD | -47,519,000USD | -178,594,000USD |
| Interest Income | — | — | — | — | 0USD | 0USD | 460,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 253,562,000USD | 293,635,000USD | 364,981,000USD | 275,879,000USD | 83,755,000USD | 78,976,000USD | 92,953,000USD | 100,430,000USD |
| Cash And Equivalents | 566,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 36,235,000USD | 41,970,000USD | 38,358,000USD | 16,486,999USD | 33,671,000USD | 28,704,000USD | 41,547,000USD | 39,855,000USD |
| Total Liabilities | 564,050,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 512,242,000USD | 501,752,000USD | 483,652,000USD | 358,948,000USD | 305,932,000USD | 275,744,000USD | 259,635,000USD | 281,537,000USD |
| Other Current Liabilities | 3,256,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 180,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -308,322,000USD | -249,219,000USD | -207,782,000USD | -176,936,000USD | -248,987,000USD | -211,484,000USD | -192,641,000USD | -211,317,000USD |
| Total Equity Including Noncontrolling Interest | -310,488,000USD | — | — | — | — | — | — | — |
| Net Receivables | 6,439,000USD | 29,847,000USD | 15,244,000USD | 11,941,000USD | 16,767,000USD | 10,619,000USD | 26,442,000USD | 31,580,000USD |
| Inventory | 4,171,000USD | 4,532,000USD | 4,789,000USD | 1,082,000USD | 2,519,000USD | 3,017,000USD | 2,436,000USD | 2,404,000USD |
| Property Plant Equipment Net | 26,813,000USD | 27,554,000USD | 28,417,000USD | 2,386,000USD | 2,573,000USD | 2,756,000USD | 2,933,000USD | 3,107,000USD |
| Goodwill | 13,481,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 57,611,000USD | 59,807,000USD | 123,800,000USD | 30,422,000USD | 31,443,000USD | 31,451,000USD | 32,453,000USD | 33,454,000USD |
| Accounts Payable | 121,050,000USD | 101,578,000USD | 86,266,000USD | 67,362,000USD | 59,155,000USD | 57,257,000USD | 52,620,000USD | 43,400,000USD |
| Short Term Debt | 80,806,000USD | 88,069,000USD | — | 55,306,000USD | 40,639,000USD | 40,182,000USD | 35,590,000USD | — |
| Common Stock | 1,000USD | 1,000USD | — | 1,000USD | 1,000USD | 1,000USD | 24,000USD | — |
| Retained Earnings | -1,078,556,000USD | -965,056,000USD | -921,786,000USD | -888,674,000USD | -631,440,000USD | -589,132,000USD | -563,052,000USD | -556,592,000USD |
| Accumulated Other Comprehensive Income | -6,982,000USD | -6,550,000USD | — | 3,347,000USD | 6,317,000USD | 6,317,000USD | 6,317,000USD | — |
| Other Current Assets | — | 4,230,000USD | 7,344,000USD | 2,586,000USD | 10,286,000USD | 9,268,000USD | 9,397,000USD | 5,794,000USD |
| Total Liab | — | 547,705,000USD | 576,734,000USD | 455,598,000USD | 332,742,000USD | 290,460,000USD | 285,594,000USD | 311,747,000USD |
| Other Current Liab | — | 312,105,000USD | 3,263,000USD | 236,280,000USD | 201,367,000USD | 173,339,000USD | 170,549,000USD | — |
| Capital Stock | — | 1,000USD | 1,000USD | 2,000USD | 2,000USD | 2,000USD | 25,000USD | 19,000USD |
| Good Will | — | 13,481,000USD | 13,481,000USD | 13,481,000USD | 13,481,000USD | 13,481,000USD | 13,481,000USD | 13,481,000USD |
| Cash | — | 3,351,000USD | 4,955,000USD | 878,000USD | 4,099,000USD | 5,800,000USD | 3,272,000USD | 77,000USD |
| Cash And Short Term Investments | — | 3,361,000USD | — | 878,000USD | 4,099,000USD | 5,800,000USD | 3,272,000USD | — |
| Net Debt | — | 103,008,000USD | 104,304,000USD | 66,788,000USD | 37,666,000USD | 35,709,000USD | 34,686,000USD | 98,891,000USD |
| Short Long Term Debt | — | 83,550,000USD | 86,779,000USD | 50,152,000USD | 39,871,000USD | 39,442,000USD | 34,876,000USD | 84,636,000USD |
| Short Long Term Debt Total | — | 106,359,000USD | — | 67,666,000USD | 41,765,000USD | 41,509,000USD | 37,958,000USD | — |
| Long Term Investments | — | 83,929,000USD | 128,040,000USD | 16,351,000USD | 2,468,000USD | 2,465,000USD | 2,420,000USD | 2,375,000USD |
| Short Term Investments | — | 10,000USD | 6,026,000USD | — | — | — | — | — |
| Property Plant Equipment Gross | — | 28,673,000USD | 28,738,000USD | 2,455,000USD | 2,640,000USD | 2,821,000USD | 2,997,000USD | 3,149,000USD |
| Common Stock Shares Outstanding | — | 6,891,000shares | 7,033,004shares | 11,604,000shares | 11,595,000shares | 11,565,000shares | 6,951,796shares | 3,763,483shares |
| Non Current Assets Total | — | 251,665,000USD | 326,624,000USD | 259,392,000USD | 50,084,000USD | 50,272,000USD | 51,406,000USD | 60,575,000USD |
| Non Current Liabilities Total | — | 45,953,000USD | 93,082,000USD | 96,650,000USD | 26,810,000USD | 14,716,000USD | 25,959,000USD | 30,210,000USD |
| Non Current Liabilities Other | — | 177,000USD | 175,000USD | 169,000USD | 165,000USD | 155,000USD | 155,000USD | 155,000USD |
| Non Currrent Assets Other | — | 145,992,000USD | 32,886,000USD | 196,752,000USD | 119,000USD | 119,000USD | 119,000USD | 8,158,000USD |
| Net Working Capital | — | -459,782,000USD | -445,294,000USD | -342,461,000USD | -272,261,000USD | -247,040,000USD | -218,088,000USD | -241,682,000USD |
| Unclassified Non Current Assets | — | -79,098,000USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | — | -83,550,000USD | 307,344,000USD | -50,152,000USD | -39,690,000USD | -38,779,000USD | -38,115,000USD | 153,501,000USD |
| Unclassified Non Current Liabilities | — | 45,776,000USD | 70,427,000USD | 96,481,000USD | 26,645,000USD | 14,561,000USD | 24,959,000USD | 15,723,000USD |
| Unclassified Equity | — | 722,385,000USD | 714,003,000USD | 708,388,000USD | 376,133,000USD | 371,328,000USD | 364,045,000USD | 345,256,000USD |
| Long Term Debt | — | — | 22,480,000USD | — | — | — | 845,000USD | 14,332,000USD |
| Current Deferred Revenue | — | — | — | — | 4,590,000USD | 4,303,000USD | 4,115,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 364,981,000USD | 92,953,000USD | 101,309,000USD | 86,527,000USD | 77,932,000USD | 81,504,000USD | — |
| Intangible Assets | 59,088,000USD | 32,453,000USD | 36,485,000USD | 40,591,000USD | 38,802,000USD | 42,540,000USD | — |
| Other Current Assets | 7,344,000USD | 9,397,000USD | 4,049,000USD | 4,810,000USD | 1,835,000USD | 3,314,000USD | — |
| Total Liab | 576,733,000USD | 285,594,000USD | 274,247,000USD | 50,288,000USD | 301,808,000USD | 223,187,000USD | — |
| Total Stockholder Equity | -207,781,000USD | -192,641,000USD | -172,938,000USD | 36,239,000USD | -223,876,000USD | -141,683,000USD | — |
| Other Current Liab | 305,110,000USD | 170,549,000USD | 98,786,000USD | 35,647,000USD | 107,078,000USD | 41,040,001USD | — |
| Common Stock | 1,000USD | 24,000USD | 16,000USD | 14,000USD | 13,000USD | 20,000USD | — |
| Capital Stock | 1,000USD | 25,000USD | 16,000USD | 17,000USD | 20,000USD | 20,000USD | — |
| Retained Earnings | -921,786,000USD | -563,052,000USD | -490,245,000USD | -375,914,000USD | -352,550,000USD | -264,125,999USD | — |
| Good Will | 13,481,000USD | 13,481,000USD | 13,481,000USD | 13,481,000USD | 13,481,000USD | 13,481,000USD | — |
| Cash | 4,955,000USD | 3,272,000USD | 3,921,000USD | 2,184,000USD | 4,338,000USD | 4,839,000USD | — |
| Cash And Short Term Investments | 10,981,000USD | 3,272,000USD | 3,921,000USD | 2,184,000USD | 4,338,000USD | 4,839,000USD | — |
| Total Current Assets | 38,358,000USD | 41,547,000USD | 46,781,000USD | 29,608,000USD | 23,003,000USD | 22,424,000USD | — |
| Total Current Liabilities | 483,652,000USD | 259,635,000USD | 250,380,000USD | 44,842,000USD | 169,420,000USD | 78,480,000USD | — |
| Net Debt | 127,588,000USD | 34,686,000USD | 124,542,000USD | -774,000USD | 150,408,000USD | 133,788,000USD | — |
| Short Term Debt | 92,276,000USD | 35,590,000USD | 109,188,000USD | 745,000USD | 58,058,000USD | 29,320,000USD | — |
| Short Long Term Debt | 86,779,000USD | 34,876,000USD | 108,429,000USD | — | 57,558,000USD | 28,896,000USD | — |
| Short Long Term Debt Total | 132,543,000USD | 37,958,000USD | 128,463,000USD | 1,410,000USD | 154,746,000USD | 138,627,000USD | — |
| Long Term Debt | 22,480,000USD | 845,000USD | 17,038,000USD | — | 3,834,699USD | 107,658,000USD | — |
| Long Term Investments | 128,040,000USD | 2,420,000USD | 0USD | — | — | — | — |
| Short Term Investments | 6,026,000USD | — | — | — | — | — | — |
| Net Receivables | 15,244,000USD | 26,442,000USD | 34,597,000USD | 21,236,000USD | 14,268,000USD | 13,126,000USD | — |
| Inventory | 4,789,000USD | 2,436,000USD | 4,214,000USD | 1,378,000USD | 2,562,000USD | 1,145,000USD | — |
| Accounts Payable | 86,266,000USD | 52,620,000USD | 40,954,000USD | 8,450,000USD | 4,284,000USD | 8,119,999USD | — |
| Property Plant Equipment Net | 28,417,000USD | 2,933,000USD | 3,665,000USD | 1,903,000USD | 2,108,000USD | 2,521,000USD | — |
| Property Plant Equipment Gross | 28,738,000USD | 2,997,000USD | 3,723,000USD | 2,070,000USD | 2,235,000USD | 2,609,000USD | — |
| Accumulated Other Comprehensive Income | -5,803,000USD | 6,317,000USD | 0USD | 0USD | -31,750USD | — | — |
| Common Stock Shares Outstanding | 11,034,000shares | 6,951,796shares | 3,722,614shares | 3,834,837shares | 3,795,753shares | 4,031,194shares | 4,031,194shares |
| Non Current Assets Total | 326,623,000USD | 51,406,000USD | 54,528,000USD | 56,919,000USD | 54,929,000USD | 59,080,000USD | — |
| Non Current Liabilities Total | 93,080,999USD | 25,959,000USD | 23,867,000USD | 5,446,000USD | 132,388,000USD | 144,707,000USD | — |
| Non Current Liabilities Other | 175,000USD | 155,000USD | 179,000USD | 4,215,000USD | 6,892USD | — | — |
| Non Currrent Assets Other | 224,637,000USD | 119,000USD | 89,000USD | 944,000USD | 538,000USD | 538,000USD | — |
| Net Working Capital | -445,294,000USD | -218,088,000USD | -203,599,000USD | -15,234,000USD | -146,417,000USD | -56,056,000USD | — |
| Unclassified Non Current Assets | -127,040,000USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | -86,779,000USD | -38,115,000USD | -108,429,000USD | — | -57,558,000USD | -28,896,000USD | — |
| Unclassified Non Current Liabilities | 70,425,999USD | 24,959,000USD | 6,650,000USD | -4,781,000USD | 87,656,409USD | 1,649,000USD | — |
| Unclassified Equity | 719,806,000USD | 364,045,000USD | 317,275,000USD | 412,122,000USD | 128,672,750USD | 122,402,999USD | — |
| Current Deferred Revenue | — | 4,115,000USD | 1,452,000USD | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 1,231,000USD | 5,190,000USD | — | — |
| Other Liab | — | — | — | 4,781,000USD | 35,700,000USD | 35,400,000USD | — |
| Other Assets | — | — | — | 944,000USD | 538,000USD | 538,000USD | — |
| Net Tangible Assets | — | — | — | -17,836,000USD | 130,682,901USD | -197,704,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 5,708,000USD |
| Stock Based Compensation | 7,224,000USD |
| Change To Account Receivables | 8,732,000USD |
| Change To Inventory | 617,000USD |
| Change To Liabilities | -8,014,000USD |
| Change In Working Capital | 3,998,000USD |
| Operating Cash Flow | -7,844,000USD |
| Capital Expenditures | -593,000USD |
| Net Investments | 2,945,000USD |
| Unclassified Investing Cash Flow | -3,061,000USD |
| Investing Cash Flow | -709,000USD |
| Net Debt Issuance | -6,319,000USD |
| Unclassified Financing Cash Flow | 10,980,000USD |
| Financing Cash Flow | 4,661,000USD |
| Effect Of Forex Changes On Cash | -497,000USD |
| Change In Cash | -4,389,000USD |
| End Cash Flow | 566,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -45,650,000USD | -33,112,000USD | -257,820,000USD | -44,048,000USD | -26,080,000USD | -6,460,000USD | -4,388,000USD | -37,582,000USD |
| Depreciation | 2,869,000USD | 1,587,000USD | 1,023,000USD | 1,010,000USD | 1,003,000USD | 1,004,000USD | 1,005,000USD | 1,006,000USD |
| Stock Based Compensation | 3,629,000USD | 5,643,000USD | 3,256,000USD | 3,279,000USD | 3,314,000USD | 4,805,000USD | 3,713,000USD | 3,613,000USD |
| Other Non Cash Items | 12,177,000USD | 3,122,000USD | 310,497,000USD | 25,311,000USD | 542,000USD | -6,757,000USD | 12,513,000USD | 22,778,000USD |
| Change To Account Receivables | 4,597,000USD | -664,000USD | 4,826,000USD | -6,148,000USD | 15,823,000USD | -8,098,000USD | 5,238,000USD | -8,288,000USD |
| Change To Inventory | 257,000USD | 509,000USD | 1,378,000USD | 496,000USD | -584,000USD | -34,000USD | 358,000USD | 412,000USD |
| Change In Working Capital | 25,868,000USD | 15,861,000USD | -48,726,000USD | 21,498,000USD | 27,228,000USD | 9,942,000USD | 19,196,000USD | 12,496,000USD |
| Total Cash From Operating Activities | -1,107,000USD | -17,471,000USD | 8,230,000USD | 7,050,000USD | 6,007,000USD | 2,534,000USD | 5,113,000USD | 2,311,000USD |
| Capital Expenditures | -3,050,000USD | -83,000USD | -300,000USD | -4USD | -150,000USD | -150,000USD | -150,000USD | -150,000USD |
| Free Cash Flow | -4,157,000USD | -17,554,000USD | 8,530,000USD | 7,050,000USD | 5,857,000USD | 2,384,000USD | 4,963,000USD | 2,161,000USD |
| Investments | -4,561,000USD | -16,987,000USD | -152,000USD | -153,000USD | -395,000USD | -195,000USD | -2,030,000USD | -150,000USD |
| Total Cashflows From Investing Activities | -9,160,000USD | — | -152,000USD | -153,000USD | -395,000USD | -195,000USD | — | -150,000USD |
| Net Borrowings | 9,938,000USD | 16,405,000USD | -5,937,000USD | -7,637,000USD | -2,393,000USD | -20,336,000USD | -4,705,000USD | — |
| Total Cash From Financing Activities | 9,144,000USD | 17,520,000USD | -11,299,000USD | -8,598,000USD | -3,084,000USD | -7,183,000USD | -4,483,000USD | 4,731,000USD |
| Dividends Paid | -525,000USD | — | — | — | — | — | — | — |
| Change In Cash | -1,604,000USD | 4,077,000USD | -3,221,000USD | -1,701,000USD | 2,528,000USD | -4,844,000USD | -1,550,000USD | 6,892,000USD |
| Begin Period Cash Flow | 4,955,000USD | 878,000USD | 4,099,000USD | 5,800,000USD | 3,272,000USD | 8,116,000USD | 9,666,000USD | 2,774,000USD |
| End Period Cash Flow | 3,351,000USD | 4,955,000USD | 878,000USD | 4,099,000USD | 5,800,000USD | 3,272,000USD | 8,116,000USD | 9,666,000USD |
| Other Cashflows From Investing Activities | -12,105,000USD | — | -8,374,000USD | -153,000USD | -200,000USD | -130,184USD | — | -148,595USD |
| Other Cashflows From Financing Activities | -794,000USD | — | -11,299,000USD | -978,309USD | -691,000USD | -6,329,000USD | — | 8,780,000USD |
| Unclassified Investing Cash Flow | 10,556,000USD | — | 8,674,000USD | — | — | — | — | — |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 19,482,000USD | 0USD | 15,000,000USD |
| Unclassified Operating Cash Flow | — | -10,572,000USD | — | — | — | — | -26,926,000USD | — |
| Unclassified Financing Cash Flow | — | 1,115,000USD | 5,937,000USD | — | — | 19,482,000USD | — | -19,049,000USD |
| Sale Purchase Of Stock | — | — | — | — | -200,000USD | 0USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -358,734,000USD | -72,807,000USD | -114,331,000USD | -23,364,000USD | -88,424,000USD | -47,519,000USD | -178,594,000USD |
| Depreciation | 4,623,000USD | 4,046,000USD | 4,146,000USD | 3,961,000USD | 3,779,000USD | 3,777,000USD | 3,750,000USD |
| Stock Based Compensation | 15,492,000USD | 15,689,000USD | 14,596,000USD | 5,280,000USD | 5,822,000USD | 5,395,000USD | 4,330,000USD |
| Other Non Cash Items | 228,468,000USD | 7,582,000USD | 9,080,000USD | -52,803,000USD | 23,794,000USD | 623,000USD | 90,862,000USD |
| Change To Account Receivables | 13,837,000USD | -6,267,000USD | -13,361,000USD | -6,968,000USD | -1,142,000USD | -598,000USD | -12,356,000USD |
| Change To Inventory | 1,799,000USD | 1,462,000USD | -2,838,000USD | 1,184,000USD | -1,417,000USD | 2,379,000USD | -1,116,000USD |
| Change In Working Capital | 113,967,000USD | 64,839,000USD | 65,802,000USD | 45,668,000USD | 13,602,000USD | 7,063,000USD | -4,069,000USD |
| Total Cash From Operating Activities | 3,816,000USD | 19,349,000USD | -20,707,000USD | -21,258,000USD | -28,664,000USD | -31,461,000USD | -60,421,000USD |
| Capital Expenditures | -133,000USD | -600,000USD | -330,000USD | -2,067,000USD | -7,000USD | -25,000USD | -584,000USD |
| Free Cash Flow | 3,683,000USD | 19,349,000USD | -21,037,000USD | -23,325,000USD | -28,664,000USD | -31,486,000USD | -61,005,000USD |
| Investments | -17,037,000USD | -2,675,000USD | -163,000USD | -2,067,000USD | 0USD | -25,000USD | -17,624,000USD |
| Total Cashflows From Investing Activities | 4,084,000USD | -2,675,000USD | -330,000USD | -2,067,000USD | -139,380,000USD | -25,000USD | -17,624,000USD |
| Net Borrowings | 438,000USD | -64,211,000USD | 728,000USD | 124,257,000USD | 345,000USD | -19,220,000USD | 15,776,000USD |
| Total Cash From Financing Activities | -5,461,000USD | -18,131,000USD | 23,582,000USD | 21,171,000USD | 28,163,000USD | -19,170,000USD | 15,776,000USD |
| Issuance Of Capital Stock | 0USD | 44,638,000USD | 35,458,000USD | 0USD | 0USD | — | — |
| Change In Cash | 1,683,000USD | -1,457,000USD | 2,545,000USD | -2,154,000USD | -501,000USD | -50,656,000USD | -62,269,000USD |
| Begin Period Cash Flow | 3,272,000USD | 4,729,000USD | 2,184,000USD | 4,338,000USD | 4,839,000USD | 55,495,000USD | 117,764,000USD |
| End Period Cash Flow | 4,955,000USD | 3,272,000USD | 4,729,000USD | 2,184,000USD | 4,338,000USD | 4,839,000USD | 55,495,000USD |
| Other Cashflows From Investing Activities | 4,217,000USD | -675,000USD | -300,000USD | -2,060,000USD | -139,380,000USD | — | — |
| Other Cashflows From Financing Activities | -30,526,000USD | 1,442,000USD | -2,604,000USD | 52,326,000USD | 47,850,000USD | 18,543,213USD | 15,776,000USD |
| Unclassified Investing Cash Flow | 17,037,000USD | 1,275,000USD | — | 4,127,000USD | — | — | — |
| Unclassified Financing Cash Flow | 24,627,000USD | 44,638,000USD | 45,458,000USD | -155,508,000USD | -160,345,740USD | -18,493,213USD | -15,776,000USD |
| Sale Purchase Of Stock | — | 0USD | -10,000,000USD | 96,000USD | 140,313,740USD | — | — |
| Dividends Paid | — | — | -10,000,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | 32,416,000USD | 208,704USD | -4,062,000USD | 4,271,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -2,154,000USD | 477,410USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | 12,763,000USD | — | 23,300,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.